Primary CNS lyphoma: can we use MATRix immunochemo in the real world?
MATRix immunochemotherapy induction therapy has produced promising results in the recent IELSG32 trial (NCT01011920) for primary CNS lymphoma (PCNSL). However, here at the British Society for Haematol... Author: VJHemOnc Added: 06/27/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2018 Category: Cancer & Oncology Source Type: podcasts
100% Response Rate with Anti-PD1 Therapy for Patients with Lymphoma
Joshua Brody, MD, PhD, of Mount Sinai Hospital, gives an overview of a clinical trial by Dana Farber that shows patients with primary central nervous system lymphoma has a 100% response rate with anti... Author: ASHReport Added: 12/09/2016 (Source: Oncology Tube)
Source: Oncology Tube - December 9, 2016 Category: Cancer & Oncology Source Type: podcasts